Wells Fargo & Company DIANTHUS THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
12,326
Previous 15,379 19.85%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-3,053 Reduced 19.85%
12,326 $0
Q1 2025

May 13, 2025
BUY
N/A
1,561 Added 11.3%
15,379 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-8,271 Reduced 37.44%
13,818 $0
Q3 2024

Nov 13, 2024
BUY
N/A
11,770 Added 114.06%
22,089 $0
Q2 2024

Aug 13, 2024
BUY
N/A
10,095 Added 4506.7%
10,319 $0
Q1 2024

May 10, 2024
BUY
N/A
150 Added 202.7%
224 $0
Q4 2023

Feb 09, 2024
BUY
N/A
24 Added 48.0%
74 $0
Q3 2023

Nov 13, 2023
BUY
N/A
50 New
50 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email